8 תוצאות
BACKGROUND OF INVENTION
Field of Invention
The present invention relates to compounds and to a method for protection of cells and tissues from irreversible injury due to lactic acidosis. More specifically, this invention relates to compounds permeable through the cell membrane and possessing a
BACKGROUND OF INVENTION
1. Field of Invention
The present invention relates to a method for prevention and treatment of harmful effect of intracellular acidosis. The method protects cells and tissues from irreversible injury due to lactic acidosis. More specifically, this invention relates to method
FIELD OF THE INVENTION
This invention generally relates to a method for the treatment of eye disorders. More specifically, it relates to a method and composition for preventing or treating hypoxia-associated ocular complications which employs at least two agents selected from the group consisting of
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention generally relates to the field of delivery vehicles for use in diagnostic and therapeutic applications, and specifically towards diagnostic and therapeutic applications involving hypoxic areas of a patient.
2. Description of
INTRODUCTION
This embodiment of invention is directed to novel treatments for `Intra Uterine Growth Restriction` (IUGR) of a human fetus, one of a long known and incurable (but treatable) maternal-fetoplacental pathology resulting significant mortality and morbidity of the fetus/neonate, it's
The embodiment of this invention is directed to an exemplary and an innovative treatment involving `Intra Uterine Growth Restriction` (IUGR) of a human fetus, a long known and incurable but treatable maternal-fetoplacental pathology, resulting in significant mortality and morbidity of the
FIELD OF THE INVENTION
The present invention relates to adhesion prevention in general and to compounds, an endoscopic insufflation system and to a method for preventing adhesion formation in particular.
BACKGROUND OF THE INVENTION
Adhesion formation is a major problem following surgical procedures
BACKGROUND OF THE INVENTION
Ischemia-reperfusion injury (IRI) involving harvested organs and allograft transplantation may in part be caused by stimulation of a newly described innate pro-inflammatory immune system (i.e. cryopyrin-inflammasome, now referred to as NLRP-3 or NALP-3 inflammasome) that